FDCPharmaceuticals
FDC Ltd — PE Ratio & Valuation Analysis
₹321.10
-2.67%
Current P/E29.48xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E20.3x45.2% above avg
✅
7.2% Discount to Industry
FDC P/E 29.48x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹16.39 | ₹423 | 25.8x |
| 2024 | ₹1858.00 | ₹499 | 0.3x |
| 2023 | ₹11.67 | ₹396 | 34x |
| 2022 | ₹12.82 | ₹271 | 21.1x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding FDC Ltd Valuation
FDC Ltd (FDC) currently trades at 29.48x earnings. The Pharmaceuticals sector average PE is 31.77x. FDC is trading at a discount to peers — may indicate relative value. Historically, FDC has traded at an average PE of 20.3x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
11.83%
Dividend Yield
1.23%
More on FDC Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.